Access Program Information
An expanded access/compassionate use protocol that allows access to Mylotarg for
relapsed/refractory AML CD33 positive patients in the USA.
Contact: [email protected]
Pfizer – CD33 Positive Acute Myelogenous Leukemia
Rare Disease: